This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Satoshi Maeda: Innovator in Medicinal Chemistry
Introduction
Satoshi Maeda is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Satoshi Maeda holds a patent for a pyrimidine derivative, which is a compound represented by the formula (I) or a salt thereof. This compound exhibits mPGES-1 inhibitory activity, making it useful as an active ingredient in medications aimed at the prophylactic and therapeutic treatment of diseases such as inflammation, pain, and rheumatism. He has 1 patent to his name.
Career Highlights
Maeda is associated with Aska Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work focuses on creating innovative solutions for various medical conditions.
Collaborations
Throughout his career, Satoshi Maeda has collaborated with notable colleagues, including Tomoaki Watanabe and Makoto Okada. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Aska Pharmaceutical Co., Ltd.
Conclusion
Satoshi Maeda's contributions to medicinal chemistry and his innovative patent for a pyrimidine derivative highlight his role as a key figure in the pharmaceutical industry. His work continues to impact the development of effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile